Supreme Court allows mail-order abortion drugs

The U.S. Supreme Court on Thursday ruled that women can continue to access abortion drugs through the mail without making an in-person doctor’s visit, while a lawsuit continues against the practice.

Justices on the high court graned two emergency requests from Danco Laboratories and GenProBio, two makers of the abortion drug mifepristone.

The manufacturers challenged a ruling in Lousiana that upheld the state’s ban on prescribing abortion drugs without an in-person doctor’s visit. In 2023, the Biden administration finalized a rule to allow the drugs to be obtained without an in-person visit.

Justices Clarence Thomas and Samuel Alito dissented from the majority’s decision. Alito said the litigation limits a state’s ability to make determinations on abortion, as granted in the high court’s 2022 decision that overturned the constitutional right to abortion.

“Louisiana’s efforts have been thwarted by certain medical providers, private organizations, and States that abhor laws like Louisiana’s and see...